Cargando…

Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy

Until recently, epilepsy medical therapy is usually limited to anti-epileptic drugs (AEDs). However, approximately 1/3 of epilepsy patients, described as drug-resistant epilepsy (DRE) patients, still suffer from continuous frequent seizures despite receiving adequate AEDs treatment of sufficient dur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Nian, Liu, Hao, Di, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580785/ https://www.ncbi.nlm.nih.gov/pubmed/23814544 http://dx.doi.org/10.2174/157015913804999540

Ejemplares similares

Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors
por: Fonseca‐Barriendos, Daniel, et al.
Publicado: (2021)

Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets
por: Li, Hanrong, et al.
Publicado: (2018)

Evolution of patients with surgically treated drug-resistant occipital lobe epilepsy
por: Aznarez, Pablo Barbero, et al.
Publicado: (2020)

TRPV1 Channel: A Potential Drug Target for Treating Epilepsy
por: Nazıroğlu, Mustafa
Publicado: (2015)

Responsive neurostimulation for treatment of pediatric drug-resistant epilepsy
por: Singhal, Nilika S., et al.
Publicado: (2018)

Factors not considered in the study of drug‐resistant epilepsy: Drug‐resistant epilepsy: Assessment of neuroinflammation
por: Campos‐Bedolla, Patricia, et al.
Publicado: (2022)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
por: Rocha, Luisa, et al.
Publicado: (2020)

Drug-Resistant Epilepsy and Surgery
por: Sheng, Jiyao, et al.
Publicado: (2018)

Neuromodulation in Drug Resistant Epilepsy
por: Rincon, Natalia, et al.
Publicado: (2021)

The Utility of Responsive Neurostimulation for the Treatment of Pediatric Drug-Resistant Epilepsy
por: Piazza, Martin G., et al.
Publicado: (2023)

Case Report: Hemispherotomy in the First Days of Life to Treat Drug-Resistant Lesional Epilepsy
por: Makridis, Konstantin L., et al.
Publicado: (2021)

Surgery for drug-resistant focal epilepsy
por: Rao, Malla Bhaskara, et al.
Publicado: (2014)

The gut microbiome in drug‐resistant epilepsy
por: Chatzikonstantinou, Simela, et al.
Publicado: (2021)

How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
por: Yu, Nian, et al.
Publicado: (2020)

Editorial: New GPCR targets and modulators to treat CNS disorders
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
por: Martin, Sarah, et al.
Publicado: (2019)

The Need for Antiepileptic Drug Chronotherapy to Treat Selected Childhood Epilepsy Syndromes and Avert the Harmful Consequences of Drug Resistance
por: Manganaro, Sheryl, et al.
Publicado: (2017)

Pilot study of focused ultrasound for drug‐resistant epilepsy
por: Lee, Cheng‐Chia, et al.
Publicado: (2021)

Antiepileptic Drug Therapy in Patients with Drug-Resistant Epilepsy
por: Park, Kang Min, et al.
Publicado: (2019)

Ictal Asystole in Drug-Resistant Focal Epilepsy: Two Decades of Experience from an Epilepsy Monitoring Unit
por: Casciato, Sara, et al.
Publicado: (2020)

Molecular diagnostics in drug‐resistant focal epilepsy define new disease entities
por: Kobow, Katja, et al.
Publicado: (2021)

Alteration of Excitation/Inhibition Imbalance in the Hippocampus and Amygdala of Drug-Resistant Epilepsy Patients Treated with Acute Vagus Nerve Stimulation
por: Ooi, Qian Yi, et al.
Publicado: (2023)

Localizing targets for neuromodulation in drug-resistant epilepsy using intracranial EEG and computational model
por: Liu, Yang, et al.
Publicado: (2022)

Harmful Waste Products as Novel Immune Modulators for Treating Inflammatory Arthritis?
por: Cope, Andrew P
Publicado: (2006)

Syncope and Epilepsy coexist in ‘possible’ and ‘drug-resistant’ epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)
por: Ungar, Andrea, et al.
Publicado: (2017)

A prospective cohort study of prognosis for newly diagnosed epilepsy in east China
por: Zhang, Yanfang, et al.
Publicado: (2013)

Managing drug-resistant epilepsy: challenges and solutions
por: Dalic, Linda, et al.
Publicado: (2016)

Diagnosis and Surgical Treatment of Drug-Resistant Epilepsy
por: Anyanwu, Chinekwu, et al.
Publicado: (2018)

Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy
por: Lakshmikanthcharan, S., et al.
Publicado: (2018)

Hemispherotomy for drug-resistant epilepsy in an Indonesian population
por: Arifin, Muhamad Thohar, et al.
Publicado: (2019)

Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
por: Smolarz, Beata, et al.
Publicado: (2021)

Network radiofrequency ablation for drug resistant epilepsy
por: Shamim, Daniah, et al.
Publicado: (2021)

Disentangling the Gordian Knot of Drug-Resistant Epilepsy
por: Karakis, Ioannis
Publicado: (2021)

Clinical predictors of drug-resistant epilepsy in children
por: KARAOĞLU, Pakize, et al.
Publicado: (2021)

Disparities in pediatric drug-resistant epilepsy care
por: LoPresti, Melissa A., et al.
Publicado: (2023)

Network based elucidation of drug response: from modulators to targets
por: Iorio, Francesco, et al.
Publicado: (2013)

Survey on Antiepileptic Drug Therapy in Patients with Drug Resistant Epilepsy
por: Sunwoo, Jun-Sang, et al.
Publicado: (2021)

Redox-Related Neuronal Death and Crosstalk as Drug Targets: Focus on Epilepsy
por: Mao, Xiao-Yuan, et al.
Publicado: (2019)

A Retrospective Analysis of the Long-Term Outcome of Drug-Resistant Epilepsy in Children Treated in Urban India
por: Raimalwalla, Toranj, et al.
Publicado: (2018)

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
por: Löscher, Wolfgang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sh5f2vherd26gint5cl3r6o8op